Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

CytoDyn

Tracked across 2 events · 18 articles · First seen Apr 20, 2026 · Last active Sep 15, 2026

Sentiment
46
Attention
6
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 90
Tech
Impact: Leronlimab is a key component of the successful regimen; positive results could boost its clinical prospects and stock value, though human trials are still needed.
Aug 10, 2026 · 6 articles
1 3
Business
Virtual Investor Conferences, a proprietary investor conference series, announced on September 14, 2026 the agenda for its upcoming Life Sciences Virtual Investor Forum, scheduled for September 17, 2026 in New York. The online event is…
Impact: CytoDyn is scheduled to present at 3:30 PM ET, giving the company a chance to address investors on its development programs.
Sep 14, 2026 · 12 articles
45 CytoDyn scheduled presentationLife Sciences Virtual...
ERGEN INTELLIGENCE
Track CytoDyn live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.